Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y017511 | OT / LL |
No other information provided. No additional AEs/PQC reported.; vaccines administered after temperature excursions; This spontaneous report was received from an Other health professional and refers to a(n) 1-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Hepatitis A Vaccine, Inactivated (VAQTA) (manufacturer unknown) Prevenar 20 (Pneumococcal vaccine conj 20v (CRM197)) . On 15-Apr-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), lot #Y017511, expiration date: 15-Apr-2026, dose number 1, (strength, dose, and vaccination scheme were not reported), administered by Subcutaneous route in Left Thigh, as Prophylaxis. On an unknown date, the vaccine underwent a temperature excursion of -9.8 Celsius Degrees during a timeframe of 2 h 3 m, with no previous temperature excursions. No adverse event was reported.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-04-28 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : , Central date : 2025-04-28 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :
Vaqta; Pneumoccocal 20